医疗补助扩展与前囚犯死亡率的关系
该队列研究纳入2009年1月1日至2018年12月31日从罗德岛州(RI,2014年1月1日实施医疗补助扩展)和北卡罗来纳州(NC,研究期间未扩展)监狱释放的18岁及以上个体,链接至2019年12月31日的死亡记录,比较医疗补助扩展后释放后死亡率的变化。与NC相比,RI前囚犯在医疗补助扩展后每季度全因死亡率持续下降72/10万人年(95%CI -108至-36),每6个月药物过量死亡下降172/10万人年(95%CI -226至-117),每12个月他杀死亡下降23/10万人年(95%CI -50至4),自杀死亡率无变化。非西班牙裔白人全因死亡率下降幅度为所有少数族裔合计的3倍,非西班牙裔黑人未获得实质性获益;性别无效应修饰,30岁及以上人群全因死亡率下降大于30岁以下人群。作者认为医疗补助扩展与RI前囚犯全因、药物过量及他杀死亡率下降相关,但获益主要见于白人,少数族裔获益甚微。
要点
- 与未扩展医疗补助的NC相比,RI医疗补助扩展后前囚犯每季度全因死亡率持续下降72/10万人年(95%CI -108至-36)。
- RI医疗补助扩展后每6个月药物过量死亡下降172/10万人年(95%CI -226至-117),包括阿片类药物和多药过量。
- RI医疗补助扩展后每12个月他杀死亡下降23/10万人年(95%CI -50至4),自杀死亡率无变化。
- 非西班牙裔白人全因死亡率下降幅度为所有少数族裔合计的3倍,非西班牙裔黑人未获得实质性获益;性别无效应修饰,30岁及以上人群获益大于30岁以下。
- 该研究为观察性队列,结果提示医疗补助扩展可能降低前囚犯死亡率,但少数族裔获益甚微。
适用人群与场景
- 2009年1月1日至2018年12月31日从RI和NC监狱释放的18岁及以上个体。
- 排除:在 ongoing judicial proceedings 期间被临时拘留者、在监禁期间死亡者、研究期间未从监禁释放者。
研究设计与关键结果
- 研究设计:队列研究,使用2009年1月1日至2018年12月31日监禁释放数据链接至2009年1月1日至2019年12月31日死亡记录,数据分析时间为2022年8月20日至2024年2月15日。
- 样本量:RI监狱释放17 824人(平均[SD]年龄38.39[10.85]岁;31 512[89.1%]男性),NC监狱释放160 861人(平均[SD]年龄38.28[10.84]岁;209 021[87.5%]男性)。
- 暴露:RI自2014年1月1日起实施全面医疗补助扩展;NC在研究期间未扩展医疗补助。
- 主要结局:与NC相比,RI前囚犯在医疗补助扩展后每季度全因死亡率持续下降72/10万人年(95%CI -108至-36)。
- 药物过量死亡:RI每6个月药物过量死亡下降172/10万人年(95%CI -226至-117),包括阿片类药物和多药过量。
- 他杀死亡:RI每12个月他杀死亡下降23/10万人年(95%CI -50至4)。
- 自杀死亡:医疗补助扩展后自杀死亡率无变化。
- 亚组:RI医疗补助扩展后,非西班牙裔白人全因死亡率持续下降幅度为所有少数族裔合计的3倍,非西班牙裔黑人未获得任何实质性获益;性别无效应修饰;30岁及以上人群全因死亡率下降大于30岁以下人群。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,RI医疗补助扩展与前囚犯全因、药物过量及他杀死亡率下降相关。
- 作者指出,这些下降主要见于白人,少数族裔在研究结局中获益甚微。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Since 2014, Medicaid expansion has been implemented in many states across the US, increasing health care access among vulnerable populations, including formerly incarcerated people who experience higher mortality rates than the general population.
OBJECTIVE: To examine population-level association of Medicaid expansion with postrelease mortality from all causes, unintentional drug overdoses, opioid overdoses, polydrug overdoses, suicides, and homicides among formerly incarcerated people in Rhode Island (RI), which expanded Medicaid, compared with North Carolina (NC), which did not expand Medicaid during the study period.
DESIGN, SETTING, AND PARTICIPANTS: A cohort study was conducted using incarceration release data from January 1, 2009, to December 31, 2018, linked to death records from January 1, 2009, to December 31, 2019, on individuals released from incarceration in RI and NC. Data analysis was performed from August 20, 2022, to February 15, 2024. Participants included those aged 18 years or older who were released from incarceration. Individuals who were temporarily held during ongoing judicial proceedings, died during incarceration, or not released from incarceration during the study period were excluded.
EXPOSURE: Full Medicaid expansion in RI effective January 1, 2014.
MAIN OUTCOMES AND MEASURES: Mortality from all causes, unintentional drug overdoses, unintentional opioid and polydrug overdoses, suicides, and homicides.
RESULTS: Between 2009 and 2018, 17 824 individuals were released from RI prisons (mean [SD] age, 38.39 [10.85] years; 31 512 [89.1%] male) and 160 861 were released from NC prisons (mean [SD] age, 38.28 [10.84] years; 209 021 [87.5%] male). Compared with NC, people who were formerly incarcerated in RI experienced a sustained decrease of 72 per 100 000 person-years (95% CI, -108 to -36 per 100 000 person-years) in all-cause mortality per quarter after Medicaid expansion. Similar decreases were observed in RI in drug overdose deaths (-172 per 100 000 person-years per 6 months; 95% CI, -226 to -117 per 100 000 person-years), including opioid and polydrug overdoses, and homicide deaths (-23 per 100 000 person-years per year; 95% CI, -50 to 4 per 100 000 person-years) after Medicaid expansion. Suicide mortality did not change after Medicaid expansion. After Medicaid expansion in RI, non-Hispanic White individuals experienced 3 times greater sustained decreases in all-cause mortality than all racially minoritized individuals combined, while non-Hispanic Black individuals did not experience any substantial benefits. There was no modification by sex. Individuals aged 30 years or older experienced greater all-cause mortality reduction after Medicaid expansion than those younger than 30 years.
CONCLUSIONS AND RELEVANCE: Medicaid expansion in RI was associated with a decrease in all-cause, overdose, and homicide mortality among formerly incarcerated people. However, these decreases were most observed among White individuals, while racially minoritized individuals received little to no benefits in the studied outcomes.
参考来源
- Perera PS, Miller VE, Fitch KV, et al. Medicaid Expansion and Mortality Among Persons Who Were Formerly Incarcerated. JAMA Netw Open. 2024. PMID: 39287949. doi:10.1001/jamanetworkopen.2024.29454
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。